<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02324465</url>
  </required_header>
  <id_info>
    <org_study_id>130470</org_study_id>
    <nct_id>NCT02324465</nct_id>
  </id_info>
  <brief_title>King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope</brief_title>
  <official_title>King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope: A Comparative Study in Ambulatory Surgery Center Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to conduct a randomized trial comparing the intubation success rate
      and time of the King Vision Video Laryngoscope to the Glidescope video laryngoscope in order
      to demonstrate the comparability of the devices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Both the King Vision and Glidescope video laryngoscopes are advanced airway devices that are
      relatively low cost and are designed to improve the efficiency of both routine and difficult
      intubation. Both systems use disposable blades, which eliminates the need for blade
      sterilization and may minimize the risk of infectious exposure to patients and improve cost
      and efficiency associated with the sterilization processing of non-disposable laryngoscopes.
      The Glidescope has been commercially available longer than the King Vision, and has been more
      frequently studied.

      Although similar in many respects, the King Vision and Glidescope systems have differing
      designs which may result in differences in speed and success in the management of routine
      and/or difficult airways.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Closed due to low enrollment
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Until Intubation With Each Device</measure>
    <time_frame>&lt;100 seconds</time_frame>
    <description>time from the introduction of the laryngoscope into the oral cavity to endotracheal tube reaching the glottic aperture</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Pulse Oximetry Saturation Value Reading During Intubation</measure>
    <time_frame>&lt;100 seconds</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Assisted Maneuvers Required to Complete Intubation (Includes All Participants in Arm)</measure>
    <time_frame>&lt;100 seconds</time_frame>
    <description>Assisted Maneuvers can include laryngeal manipulation, head lift, Backward Upward Rightward Pressure, stylet removed, Cricoid pressure, scope manipulation and bougie.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants With Adverse Events</measure>
    <time_frame>during and immediately after procedure (approx 180 minutes)</time_frame>
    <description>Notation of any injury to lips, teeth, soft tissue.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Difficult Intubation</condition>
  <arm_group>
    <arm_group_label>King Vision Video Laryngoscope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patient would be randomized to intubation via use of the King Vision VL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glidescope Video Laryngoscope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patient would be randomized to intubation via use of the Glidescope VL</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>King Vision Video Laryngoscope</intervention_name>
    <description>Intubation via King Vision Video Laryngoscope</description>
    <arm_group_label>King Vision Video Laryngoscope</arm_group_label>
    <other_name>King Systems</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glidescope Video Laryngoscope</intervention_name>
    <description>Intubation via Glidescope Video Laryngoscope</description>
    <arm_group_label>Glidescope Video Laryngoscope</arm_group_label>
    <other_name>Verathon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients scheduled for elective, ambulatory surgery requiring general anesthesia
             and endotracheal intubation

        Exclusion Criteria:

          -  Patients who require rapid sequence induction and intubation or fiberoptic intubation.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas Hester, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>December 18, 2014</study_first_submitted>
  <study_first_submitted_qc>December 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2014</study_first_posted>
  <results_first_submitted>May 22, 2018</results_first_submitted>
  <results_first_submitted_qc>April 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 23, 2019</results_first_posted>
  <last_update_submitted>April 1, 2019</last_update_submitted>
  <last_update_submitted_qc>April 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Doug Hester</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 4, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/65/NCT02324465/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>King Vision Video Laryngoscope</title>
          <description>The patient would be randomized to intubation via use of the King Vision VL then Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
        </group>
        <group group_id="P2">
          <title>Glidescope Video Laryngoscope</title>
          <description>The patient would be randomized to intubation via use of the Glidescope VL then King Vision VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>device failure</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>King Vision Video Laryngoscope</title>
          <description>The patient would be randomized to intubation via use of the King Vision VL then Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
        </group>
        <group group_id="B2">
          <title>Glidescope Video Laryngoscope</title>
          <description>The patient would be randomized to intubation via use of the Glidescope VL then King Vision VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Until Intubation With Each Device</title>
        <description>time from the introduction of the laryngoscope into the oral cavity to endotracheal tube reaching the glottic aperture</description>
        <time_frame>&lt;100 seconds</time_frame>
        <group_list>
          <group group_id="O1">
            <title>King Vision Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the King Vision VL or Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the Glidescope VL or King Vision VL
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
          </group>
        </group_list>
        <measure>
          <title>Time Until Intubation With Each Device</title>
          <description>time from the introduction of the laryngoscope into the oral cavity to endotracheal tube reaching the glottic aperture</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.3" lower_limit="10.0" upper_limit="69.7"/>
                    <measurement group_id="O2" value="27.2" lower_limit="9.6" upper_limit="53.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pulse Oximetry Saturation Value Reading During Intubation</title>
        <time_frame>&lt;100 seconds</time_frame>
        <group_list>
          <group group_id="O1">
            <title>King Vision Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the King Vision VL or Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the Glidescope VL or King Vision VL
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pulse Oximetry Saturation Value Reading During Intubation</title>
          <units>percentage of oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.39" lower_limit="85" upper_limit="100"/>
                    <measurement group_id="O2" value="97.0" lower_limit="82" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Assisted Maneuvers Required to Complete Intubation (Includes All Participants in Arm)</title>
        <description>Assisted Maneuvers can include laryngeal manipulation, head lift, Backward Upward Rightward Pressure, stylet removed, Cricoid pressure, scope manipulation and bougie.</description>
        <time_frame>&lt;100 seconds</time_frame>
        <group_list>
          <group group_id="O1">
            <title>King Vision Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the King Vision VL or Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the Glidescope VL or King Vision VL
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Assisted Maneuvers Required to Complete Intubation (Includes All Participants in Arm)</title>
          <description>Assisted Maneuvers can include laryngeal manipulation, head lift, Backward Upward Rightward Pressure, stylet removed, Cricoid pressure, scope manipulation and bougie.</description>
          <units>assisted maneuvers</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Backward Upward Rightward Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>stylet removed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cricoid pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>bougie</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>scope manipulation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Adverse Events</title>
        <description>Notation of any injury to lips, teeth, soft tissue.</description>
        <time_frame>during and immediately after procedure (approx 180 minutes)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>King Vision Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the King Vision VL or Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope Video Laryngoscope</title>
            <description>The patient would be randomized to intubation via use of the Glidescope VL or King Vision VL
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events</title>
          <description>Notation of any injury to lips, teeth, soft tissue.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>approximately 180 minutes</time_frame>
      <group_list>
        <group group_id="E1">
          <title>King Vision Video Laryngoscope</title>
          <description>The patient would be randomized to intubation via use of the King Vision VL or Glidescope VL
King Vision Video Laryngoscope: Intubation via King Vision Video Laryngoscope</description>
        </group>
        <group group_id="E2">
          <title>Glidescope Video Laryngoscope</title>
          <description>The patient would be randomized to intubation via use of the Glidescope VL or King Vision VL
Glidescope Video Laryngoscope: Intubation via Glidescope Video Laryngoscope</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Lip Trauma</sub_title>
                <description>minor lacerations associated with intubation procedure</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study terminated early due to clinical equipoise</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Doug Hester</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>6153439419</phone>
      <email>doug.hester@vanderbilt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

